Journal article icon

Journal article

Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG – RAPID Trial): A structured summary of a study protocol for a randomised controlled trial

Abstract:

In December 2019, the first reports of COVID-19, a disease caused by a new severe acute respiratory syndrome of coronaviral etiology (SARS-CoV-2), were received from Wuhan (Hubei Province, China). Since then, the disease has become a global pandemic. To date, more than 2.8 million people have died (WHO, 2021). SARS-CoV-2 virus became the seventh known variant of coronavirus pathogenic to humans. The aim – to assess the impact of SARS-CoV-2 infection on the prevalence of stroke in the countrie...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1186/s13063-021-05076-0

Authors

More by this author
Role:
Author
ORCID:
0000-0003-1220-0301
More by this author
Role:
Author
ORCID:
0000-0003-0851-8536
More by this author
Role:
Author
ORCID:
0000-0002-6428-6066
More by this author
Role:
Author
ORCID:
0000-0001-7841-7322
More by this author
Role:
Author
ORCID:
0000-0002-1171-0548



Publisher:
BioMed Central
Journal:
Trials More from this journal
Volume:
22
Issue:
1
Pages:
202-202
Article number:
202
Publication date:
2021-03-10
DOI:
EISSN:
1745-6215
ISSN:
1745-6215


Language:
Ukrainian
Keywords:
Pubs id:
1280725
Local pid:
pubs:1280725
Source identifiers:
W3134959801
Deposit date:
2026-04-28
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP